Community respiratory virus infections following lung transplantation

Transpl Infect Dis. 2001 Sep;3(3):138-48. doi: 10.1034/j.1399-3062.2001.003003138.x.


Respiratory infections remain a significant cause of morbidity and mortality after lung transplantation. In addition to cytomegalovirus, the community respiratory viruses such as respiratory syncytial virus (RSV), parainfluenza virus (PIV), influenza virus, and adenovirus, are important causes of infection in transplant recipients, often involve the lower respiratory tract, and may be associated with significant morbidity and mortality. In this review, we summarize the current state of knowledge regarding the epidemiology, clinical manifestations, diagnosis, treatment and outcomes associated with RSV, PIV, influenza virus, and adenovirus infections in lung transplant recipients.

Publication types

  • Review

MeSH terms

  • Adenoviridae Infections / diagnosis
  • Adenoviridae Infections / epidemiology
  • Adenoviridae Infections / therapy
  • Community-Acquired Infections / virology
  • Humans
  • Influenza, Human / diagnosis
  • Influenza, Human / epidemiology
  • Influenza, Human / therapy
  • Lung Transplantation / adverse effects*
  • Paramyxoviridae Infections / diagnosis
  • Paramyxoviridae Infections / epidemiology
  • Paramyxoviridae Infections / therapy
  • Postoperative Complications
  • Respiratory Syncytial Virus Infections / diagnosis
  • Respiratory Syncytial Virus Infections / epidemiology
  • Respiratory Syncytial Virus Infections / therapy
  • Respiratory Tract Infections* / diagnosis
  • Respiratory Tract Infections* / epidemiology
  • Respiratory Tract Infections* / therapy
  • Respiratory Tract Infections* / virology
  • Treatment Outcome